GPCR (Structure Therapeutics Inc. American Depositary Shares) Stock Analysis - SEC Filings

Structure Therapeutics Inc. American Depositary Shares (GPCR) is a publicly traded Healthcare sector company. As of May 20, 2026, GPCR trades at $36.92 with a market cap of $2.57B and a P/E ratio of -45.88. GPCR moved +2.84% today. Year to date, GPCR is -41.26%; over the trailing twelve months it is +49.45%. Its 52-week range spans $13.22 to $94.90. Analyst consensus is strong buy with an average price target of $110.69. Rallies surfaces GPCR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find GPCR SEC filings?

Rallies organizes GPCR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

GPCR Key Metrics

Key financial metrics for GPCR
MetricValue
Price$36.92
Market Cap$2.57B
P/E Ratio-45.88
EPS$-0.80
Dividend Yield0.00%
52-Week High$94.90
52-Week Low$13.22
Volume1.20M
Avg Volume0
Revenue (TTM)$0
Net Income$-141.20M
Gross Margin0.00%

Latest GPCR News

GPCR Analyst Consensus

15 analysts cover GPCR: 0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.69.

Common questions about GPCR

Where can I find GPCR SEC filings?
Rallies organizes GPCR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show GPCR 10-K and 10-Q filings?
Rallies organizes GPCR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is GPCR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GPCR. It does not provide personalized investment advice.
GPCR

GPCR